BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 17636808)

  • 1. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Stern A; Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
    Green H; Paul M; Vidal L; Leibovici L
    Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
    Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC
    Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
    Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
    Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis carinii pneumonia: pitfalls of prophylaxis.
    Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P
    J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
    Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
    BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial.
    Abe Y; Fujibayashi K; Nishizaki Y; Yanagisawa N; Nojiri S; Nakano S; Tada K; Yamaji K; Tamura N
    Acta Med Okayama; 2019 Feb; 73(1):85-89. PubMed ID: 30820060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
    Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
    Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.
    Walmsley SL; Khorasheh S; Singer J; Djurdjev O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):498-505. PubMed ID: 9859964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumocystis pneumonia in patients with immunosuppression other than HIV infection].
    Adler D; Chenivesse C; Similowski T; Soccal PM
    Rev Med Suisse; 2008 Nov; 4(180):2525-6, 2528-30. PubMed ID: 19127897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.
    Otani T; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Hirata S; Fujitaka K; Hamada H; Sugiyama E; Hattori N
    Pulm Pharmacol Ther; 2021 Apr; 67():101999. PubMed ID: 33571651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
    Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
    Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
    Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
    Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
    Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.